Research Article - Biomedical Research (2017) Volume 28, Issue 21
Effect of risk factors on expression of vascular endothelial growth factor in precancerous lesions of gastric cancer
- *Corresponding Author:
- Houbo Deng
Department of Liver and Stomach Diseases
Affiliated Hospital of Changchun University of Traditional
Chinese Medicine, PR China
Accepted on November 29, 2017
Objective: To investigate the relationship between the various risk factors and Vascular Endothelial Growth Factor (VEGF) expression in the precancerous lesions of gastric cancer.
Methods: The patients with PLGC confirmed by gastroscope and pathology results were collected. The expression of VEGF was detected by immunohistochemical. The relationship of the expression of VEGF with smoking, drinking, diet condition of patients, personal history, and family history of Helicobacter pylori (H. pylori) infection was analysed.
Results: Single factor analysis showed that five risk factors (smoking, bile reflux, tumor family history, personal history of chronic atrophic gastritis and H. pylori infection) between VEGF positive group and VEGF negative group had statistically significant (P<0.05), the multiple factors logistic regression analysis showed that smoking (OR=3.386, 95% CI: 1.373~8.349), bile reflux (OR=3.027, 95% CI: 1.176~7.795), H. pylori infection (OR=3.884, 95% CI: 1.345~11.212) had affection on VEGF expression in PLGC.
Conclusion: Smoking, bile reflux and H. pylori infection were influencing factors for VEGF expression in PLGC.
Vascular endothelial growth factor, Risk factors, Precancerous lesion, Logistic regression analysis.
Gastric cancer is the 2nd most common cause of death among all cancers and is the 4th most common cancers in the world. The number of deaths due to gastric cancer is about 800,000 annually . The initial diagnosis of gastric cancer is often delayed because most patients are asymptomatic in the early stage, so unfortunately, gastric cancers are usually diagnosed at their advanced stages . With the rise in endoscopic utilization, driven in large part by individuals being screened for Gastroesophageal Reflux Disease (GERD), the detection of precancerous gastric lesions has increased . Currently, management of gastric precancerous lesions varies from surgery to annual surveillance for dysplasia [4,5] and from no treatment to surveillance every 3 to 5 y for less advanced lesions [6,7]. Prevention and delay of Precancerous Lesions of Gastric Cancer (PLGC) is an important way to reduce the incidence of gastric cancer, but the mechanism of malignant transformation of gastric mucosa is not yet fully understood, the prevention and treatment of precancerous lesions is not ideal. Vascular Endothelial Growth Factor (VEGF) is associated with the occurrence , development and prognosis of gastric cancer, which is one of the factors involved in the process of gastric mucosal evolution with relatively thorough study, however it is relatively rare in the study of precancerous lesions and its relationship with the risk factors of gastric cancer has not been reported. This study aims to explore the relationship between PLGC risk factors and VEGF expression and to understand the pathogenesis of different risk factors to help us develop better clinical intervention programs.
Materials and Methods
120 cases of patients with intestinal metaplasia and heterosexual hyperplasia treated in Department of Gastroenterology, Hebei North College Affiliated Hospital from December 2012 to December 2013 were selected for this study, and the individual situation was asked. The patients with severe cardiovascular, cerebrovascular, liver and kidney disease, cancer, blood system diseases and stomach surgery history were excluded. Among 120 cases of PLGC patients, 68 cases were males and 52 of females, aged from 35 to 72 y old with the median age of 58.9. Case-control study was applied in this research, and subjects were categorized into VEGFnegative group and VEGF-positive group.
(1) Gastric mucosal biopsy specimens were fixed in 10% formaldehyde solution, embedded and sliced with conventional paraffin, the immunohistochemistry was used for VEGF detection (mouse anti-human VEGF monoclonal antibody from Beijing Zhong Jin Jinqiao Biological Co., Ltd.). The professional pathologist read the pathological sections to judge. (2) The risk factors included in this study were smoking (average more than 5 cigarettes daily and smoking more than 1 year), drinking (more than 2 times per week and more than 500 ml of beer or 250 ml of rice wine or 50 ml of white wine at one time); high salt diet (daily salt>6 g); regular consumption of baked food (average more than 2 times per week), aspirin and other non-steroidal anti-inflammatory drugs that use for more than 3 months; tumor family history, including one, two, thirddegree relatives investigated in the case of gastrointestinal cancer cases); H. pylori infection history. Patients were enrolled in a questionnaire. (3) If the risk factor above occurred, it will be assigned to 1, if not, it will be assigned to 0.
Inclusion criteria: age 35 to 72; absent of other cancers .
VEGF positive determination: VEGF is mainly located in the cytoplasm, immunohistochemical positive reaction is present as yellowish brown particles. The number of positive cells was calculated as follows: 5 high power fields were observed at random in every slice, and the number of positive cells in 100 cells per field was counted, and the mean value was calculated and cell positive index was expressed as a percentage. Dyeing strength: no staining is 0 point; light yellow is 1 point; yellow is 2 points; brownish yellow or reddish brown is 3 points. Positive cells percentage: no positive cells is 0 point; positive cells<25% is 1 point; positive cells between 25% to 50% is 2 points; 50% to 75% is 3 points; positive cells ≥ 75% is 4 points. Two items were added: 0 point is (-), 1-2 points is (+), 3 to 4 is (++), 5 to 7 is (+++), and + ~ +++ all represent positive.
The study was carried out in compliance with the Declaration of Helsinki of the World Medical Association, and according to a protocol approved by the Ethical Committee of Hebei North College Affiliated Hospital, the approval number is 2012006. The objectives of the study were explained to the study participants and verbal consent was obtained before interviewing each participant.
SPSS19.0 was used for analysis, single factor analysis for comparison of group classification data employed χ2 test. Multivariate logistic regression analysis was used to determine the statistically significant variables in univariate analysis, P<0.05 was considered statistically significant.
Single factor analysis
The results indicated that five risk factors were included, such as smoking, bile reflux, family history of cancer, history of chronic atrophic gastritis and H. pylori infection. There were significant differences between VEGF-negative group and VEGF-positive group (P<0.05). The differences in the drinking, high-salt diet, regular consumption of baked food and long-term aspirin between the two groups were not statistically significant (P>0.05, in Table 1).
|Risk factors||Number of cases||VEGF (+)||VEGF (-)||P value|
|Regular consumption of baked food||26||17||9||0.638|
|Family history of cancer*||23||20||3||0.046|
|History of chronic atrophic gastritis*||26||23||3||0.017|
|H. pylori infection*||79||62||17||0.003|
Note: comparison between the two groups, *P<0.05.
Table 1. Effects of different risk factors on the expression of VEGF in PLGC.
Logistic regression analysis
Multivariate logistic regression analysis was performed on smoking, bile reflux, family history of cancer, history of chronic atrophic gastritis and H. pylori infection. The results showed that smoking, bile reflux and H. pylori infection had effect on the expression of VEGF in PLGC. Exp (B) values were 3.386, 3.027 and 3.84, respectively, and Exp (B) 95% CI were from 373 to 8.349, 7.795, 1.345 to 11.212, respectively (Table 2).
|Risk factors||B||S.E.||Wald||df||Sig.||Exp (B)||Exp (B) 95% CI|
|Family history of cancer||0.777||0.540||2.066||1||0.151||2.174||0.754~6.269|
|History of chronic atrophic gastritis||0.173||0.539||0.103||1||0.748||1.189||0.413~3.421|
|H. pylori infection||1.357||0.541||6.292||1||0.012||3.884||1.345~11.212|
Table 2. Results of logistic regression analysis of different risk factors.
Discussion and Conclusion
PLGC, including gastric mucosal metaplasia and heterosexual hyperplasia , is the key to the occurrence of gastric cancer. However, the current mechanism of precancerous lesions evolved into gastric cancer is not clear. Studies have shown that VEGF is more clearly involved in the process of gastric mucosal evolution, and related to the occurrence, development and prognosis of gastric cancer. From understanding the correlation between different risk factors and high expression of VEGF, we can develop effective preventive measures and find effective means of intervention. Previous studies have found that poor eating habits increase the risk of PLGC, including smoking, drinking, high salt diet, regular consumption of baked meat, family history, chronic atrophic gastritis personal history, H. pylori infection, etc. [11,12].
In this study, smoking was a risk factor to induce the high expression of VEGF in precancerous lesions. The difference of univariate analysis was statistically significant and the OR value for multivariate logistic regression analysis was 3.386. Smoking had different effect on the expression of VEGF by report. In China, Wang et al.  found that smoking can induce VEGF expression increased, while Berent et al.  reported that VEGF expression was not affected by smoking. This study showed that smoking is a related risk factor, suggesting that smoking through the VEGF pathway to promote gastric cancer. There was no significant difference in drinking by single factor analysis, which was not a risk factor for high expression of VEGF in precancerous lesions. Lu et al.  found that alcohol can promote the growth of breast tumors by stimulating VEGF-dependent angiogenesis. Tan et al.  demonstrated that long-term drinking will stimulate the expression of VEGF, promote tumor angiogenesis, and related to the amount of alcohol intake, and the results of this study is inconsistent, the reason, the study may not be the type of alcohol consumption of patients classified and other factors. At the same time, high-salt diet, regular consumption of smoked roasted meat without food, indicating that it may be through other factors to promote gastric mucosal malignancy, rather than VEGF.
Individual cases include aspirin administration and other nonsteroidal drugs, bile reflux, chronic atrophic gastritis personal history and H. pylori infection. Among them, the difference between univariate analysis for aspirin and other non-steroidal drug was statistically significant. The study reported  aspirin had anti-proliferation and anti-apoptosis effect on myeloma cells in vitro by the regulation of Bcl-2 and Bax pathway to inhibit VEGF expression. In this study, we found that there was statistical significance in bile reflux, chronic atrophic gastritis history and H. pylori infection by a single factor analysis, but the multivariate logistic regression analysis showed that the history of chronic atrophic gastritis is not the risk factor inducing elevated VEGF expression. Bile reflux and H. pylori infection are risk factors for inducing the high expression of VEGF in precancerous lesions. And deoxycholic acid had a stronger role in promoting the expression in esophageal cancer cells than ursodeoxycholic acid, suggesting that the bile salt has a stronger potential carcinogenicity . H. pylori is a class I (i.e. affirmative) carcinogen of human gastric cancer. H. pylori infection is an important pathogenic factor that triggers PLGC, which is closely related to the occurrence of gastric cancer. H. pylori infection can upregulate the expression of VEGF in gastric cancer patients . H. pylori infection may induce COX-2 high expression in PLGC, which further up-regulates VEGF expression . Moreover, H. pylori induced VEGF production in gastric epithelial cells through hypoxia-inducible factor 1α (HIF-1α)- dependent pathways.
In summary, the results of this study suggest that smoking, bile reflux, H. pylori infection are risk factors for elevated VEGF expression in PLGC.
Several limitations of this study should be considered. Firstly, this research was a cross-sectional study; the mechanism involved in the interactive effect is still unclear. Further studies are needed to unravel this. Secondly, the sample size is not big enough. However, the study setting is a modern, high level comprehensive medical institution with sophisticated clinical diagnosis facilities and medical record management. Thus, the data used can be deemed reliable.
- Daniyal M, Ahmad S, Ahmad M. Risk factors and epidemiology of gastric cancer in Pakistan. Asian Pacific J Cancer Prev 2015; 16: 4821.
- Mehrabian AA, Esnaashari F, Zham H. Gastric cancer prevalence, according to survival data in Iran (National Study-2007). Iran J Publ Health 2010; 39: 27-31.
- Richter JE. Gastrooesophageal reflux disease. Best Pract Res Clin Gastroenterol 2007; 21: 609-631.
- Wu JT, Zhou J, Naidoo N. Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions. Asia‐pacific J Clin Oncol 2016; 11: 406-415.
- Bin LV, Gastroenterology DO. The estimate on risk of gastric cancer in the patients with gastric precancerous lesions. Med Philos 2015; 16: 135-140.
- Dinis-Ribeiro M, Lopes C, Da CPA. We would welcome guidelines for surveillance of patients with gastric atrophic chronic and intestinal metaplasia. Helicobacter 2008; 13: 75-79.
- Shakhatreh MH, Duan Z, Avila N. Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy. Clin Gastroenterol Hepatol Off Clin Pract Am Gastroenterol Assoc 2015; 13: 280-286.
- Abdel-Rahman O. Targeting vascular endothelial growth factor (VEGF) pathway in gastric cancer: Preclinical and clinical aspects. Crit Rev Oncol Hematol 2015; 93: 18-24.
- You WC, Lian Z, Gail MH. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Nat Cancer Inst 2000; 92: 1607-1612.
- Zhang HJ, Jin Z, Cui RL. Pathological assessment of gastric mucosa using OLGA system. Chin J Dig Endosc 2014; 31: 121-125.
- Wu Y, Fan Y, Jiang Y. Analysis of risk factors associated with precancerous lesion of gastric cancer in patients from eastern China: a comparative study. J Cancer Res Ther 2013; 9: 205-209.
- Zhou ZM, Tian F. The analysis of risk factors of intestinal metaplasia in gastric mucosa. J Shandong Med Coll 2011; 33: 115-118.
- Wang L, Cheng DY, Zhang Y. The study of the effect of smoking on vascular endothelial growth factor and the relationship with chronic obstructive pulmonary disease. Sichuan Med J 2012; 33: 1544-1546.
- Berent D, Macander M, Szemraj J. Vascular endothelial growth factor A gene expression level is higher in patients with major depressive disorder and not affected by cigarette smoking, hyperlipidemia or treatment with statins. Acta Neurobiol Exp (Wars) 2014; 74: 82-90.
- Lu Y, Ni F, Xu M. Alcohol promotes mammary tumor growth through activation of VEGF-dependent tumor angiogenesis. Oncol Lett 2014; 8: 673-678.
- Tan W, Bailey AP, Shparago M. Chronic alcohol consumption stimulates VEGF expression, tumor angiogenesis and progression of melanoma in mice. Cancer Biol Ther 2007; 6: 1211-1217.
- Ding JH, Yuan LY, Huang RB. Aspirin inhibits proliferation and induces apoptosis of multiple myeloma cells through regulation of Bcl-2 and Bax and suppression of VEGF. Eur J Haematol 2014; 93: 329-339.
- Burnat G, Rau T, Elshimi E. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett’s esophageal mucosa and adenocarcinoma cell line. Scand J Gastroenterol 2007; 42: 1460-1465.
- Ou YR, Kang M, Zhou L. Infection with L-form of Helicobacter pylori and expressions of MIF, MMP9 and VEGF in gastric carcinoma. J South Med Univ 2014; 34: 180-187.
- Liu D, He Q, Liu C. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia. J Gastroenterol Hepatol 2010; 25: 795-799.
- Kang MJ, Song EJ, Kim BY. Helicobacter pylori Induces vascular endothelial growth factor production in gastric epithelial cells through hypoxia-inducible factor-1α-dependent pathway. Helicobacter 2014; 19: 476-483.